Detalhe da pesquisa
1.
Phase I trial of vandetanib in combination with gemcitabine and capecitabine in patients with advanced solid tumors with an expanded cohort in pancreatic and biliary cancers.
Invest New Drugs
; 34(2): 176-83, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26715573